Cytovance recently appeared on the Outsourced Pharma Large Molecule Capabilities Update to share how our available capacity, experince in microbial and mammalian expression systems, US-based manufacturing facilities, and high scale-up success rate are helping industry customers meet product milestones. View the video below to hear from Stijn Cattaert, our Director of Business Development, on the
Outsourced Pharma Capabilities Update – October 2026 Read More »
